Dr. Theodore John Giuffrida, MD

Dr. Giuffrida practices at The Derm Group in Wellington, Florida.

Dr. Giuffrida's NPI, 1255357182, was assigned on July 14, 2006. Dr. Giuffrida graduated from Emory School of Medicine in 1998. Dr. Giuffrida holds Florida license ME80876.

Dr. Giuffrida's primary practice is The Derm Group, at 11924 Forest Hill Blvd, Wellington, FL 33414 in Palm Beach County. The practice phone is (305) 461-2000.

Dr. Giuffrida's primary practice is The Derm Group in Wellington, Florida. The medical group on file is The Derm Group. Dmand AI also links Dr. Giuffrida to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Giuffrida practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Giuffrida's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Giuffrida is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Giuffrida's licenses on file in 2 states: Florida and Georgia.

CMS data shows 1,447 Medicare services from Dr. Giuffrida across 17 procedure codes in 2024, for 304 Medicare patients. Medicare paid $337,371 for them. Every service was in an office.

CMS counts 304 Medicare patients who saw Dr. Giuffrida in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Giuffrida's median patient age at 65, with 39% women.

In 2024, Dr. Giuffrida wrote 196 Medicare Part D claims for 118 patients. 98% of them were for generic drugs. CMS names the drug for 176 of them, across 4 drugs with 11 or more claims each, at $1,362 in total drug cost. In 2023, CMS named 137 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Giuffrida for performance year 2024, reported individually. Dr. Giuffrida accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 24 procedures of melanoma (skin cancer) excision by Dr. Giuffrida, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Giuffrida. The most frequent topics are Skin Neoplasms. Dr. Giuffrida's most frequent co-authors are Gloria Patricia Jimenez, MD and Keyvan Nouri, MD.

CMS Open Payments shows 3 general payments to Dr. Giuffrida from 2 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $245.

Dmand AI lists 3 awards for Dr. Giuffrida.

Dr. Giuffrida graduated from Emory School of Medicine in 1998. Dr. Giuffrida is a member of AAD, American College of Mohs Surgery and ASDS.

Dr. Giuffrida is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.